Simultaneous bilateral mPCNL combined with antegrade flexible ureteroscopic lithotripsy for calculi in horseshoe kidney:a case report and feasibility analysis
10.12483/j.issn.1009-8291.2026.06.015
- VernacularTitle:同期双侧微通道经皮肾镜取石术联合顺行输尿管软镜碎石术治疗马蹄肾双肾结石病例报告并可行性分析
- Author:
Shuaiqi CHEN
1
;
Huijun FAN
2
;
Zhao TANG
1
;
Xinjun ZHANG
1
;
Feng ZHU
1
;
Huiqing ZHANG
1
Author Information
1. Department of Urology, The First Affiliated Hospital of Henan Medical University, Weihui 453100, China
2. Department of Ultrasound, The First Affiliated Hospital of Henan Medical University, Weihui 453100, China
- Publication Type:Journal Article
- Keywords:
horseshoe kidney;
bilateral renal calculi;
minimally invasive percutaneous nephrolithotomy;
antegrade flexible ureteroscopy
- From:
Journal of Modern Urology
2026;31(6):599-602
- CountryChina
- Language:Chinese
-
Abstract:
Objective To report the first case of renal calculi in a patient with horseshoe kidney (HSK) treated with simultaneous bilateral minimally invasive percutaneous nephrolithotomy (SB-mPCNL) combined with antegrade flexible ureteroscopy lithotripsy (A-FURS), and to analyze the feasibility of the surgical approach. Case Report A 57-year-old male patient was admitted due to “right lumbago and abdominal pain for 10 days”.Computed tomography urography (CTU) revealed bilateral nephrolithiasis with HSK.The patient underwent SB-mPCNL combined with A-FURS.The operation time was 185 min, with the lithotripsy and stone clearance time accounting for 80 min, and the estimated blood loss being approximately 30 mL.A plain abdominal radiograph conducted on the 4th postoperative day showed complete clearance of stones.Bilateral nephrostomy tubes were removed on the 6th postoperative day.The patient recovered uneventfully and was discharged on the 7th postoperative day.The safety and feasibility of this combined surgical modality were analyzed based on relevant literature. Conclusion SB-mPCNL combined with A-FURS is a safe, effective and feasible therapeutic option for bilateral nephrolithiasis in patients with HSK, which is worthy of further clinical verification.
